Oncology

The incidence of cancer in individuals under 50 has risen by nearly 80% in the last three decades.

Simultaneously, there has been a significant increase in the launch of innovative oncology medicines,

particularly in immune oncology.

Our oncology focus reflects the urgency to support developments in

this field, addressing the growing cancer burden and contributing to the advancement of cancer care.